A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors

被引：30
|
作者：
Rani, Sudesh [1 ]
Raheja, Konpal [1 ]
Luxami, Vijay [1 ]
Paul, Kamaldeep [1 ]
机构：
[1] Thapar Inst Engn & Technol, Sch Chem & Biochem, Patiala 147001, Punjab, India
来源：
BIOORGANIC CHEMISTRY | 2021年 / 113卷
关键词：
Non-steroidal aromatase; Structure-activity relationship; Breast cancer; Heterocycles; Medicinal chemistry; BREAST-CANCER; MOLECULAR DOCKING; BIOLOGICAL CHARACTERIZATION; SELECTIVE INHIBITORS; ADJUVANT TREATMENT; ESTROGEN-RECEPTOR; HIGHLY POTENT; DERIVATIVES; TAMOXIFEN; MECHANISM;
D O I：
10.1016/j.bioorg.2021.105017
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Breast cancer, emerging malignancy is common among women due to overexpression of estrogen. Estrogens are biosynthesized from androgens by aromatase, a cytochrome P450 enzyme complex, and play a pivotal role in stimulating cell proliferation. Therefore, deprivation of estrogen by blocking aromatase is considered as the effective way for the inhibition and treatment of breast cancer. In recent years, various non-steroidal heterocyclic functionalities have been extensively developed and studied for their aromatase inhibition activity. This review provides information about the structural-activity relationship of heterocycles (Type II) towards aromatase. This aids the medicinal chemist around the significance of different heterocyclic moieties and helps to design potent aromatase inhibitors.
引用
收藏
页数：27
相关论文
共 50 条
  • [21] Non-steroidal aromatase inhibitors based on a biphenyl scaffold: Synthesis, in vitro SAR, and molecular modelling
    Jackson, Toby
    Woo, L. W. Lawrence
    Trusselle, Melanie N.
    Purohit, Atul
    Reed, Michael J.
    Potter, Barry V. L.
    CHEMMEDCHEM, 2008, 3 (04) : 603 - 618
  • [22] Evidence for new non-steroidal human aromatase inhibitors and comparison with equine aromatase inhibition for an understanding of the mammalian active site
    Auvray, P
    Moslemi, S
    Sourdaine, P
    Galopin, S
    Séralini, GE
    Enguehard, C
    Dallemagne, P
    Bureau, R
    Sonnet, P
    Rault, S
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (06) : 451 - 462
  • [23] Nanoemulsion-based transdermal delivery of third-generation steroidal and non-steroidal aromatase inhibitors in preclinical models
    Gao, Lanyang
    Gao, Lin
    Huang, Shiyao
    Sun, Lei
    Li, Mei
    Shen, Chen
    Chen, Youyou
    Tan, Ruihao
    Chen, Yuji
    Zhan, Chengguo
    Wieland, Frank Heinrich
    Liu, Yingying
    Zhang, Yinan
    Luo, Yao
    CELL PROLIFERATION, 2025, 58 (03)
  • [24] Bone safety profile of steroidal aromatase inhibitor in comparison to non-steroidal aromatase inhibitors in postmenopausal women with breast cancer: A network meta-analysis.
    Chen, Shanshan
    Lan, Bo
    Lv, Dan
    Ma, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Effects of a non-steroidal aromatase inhibitor on ovarian function in cattle
    Yapura, M. Jimena
    Mapletoft, Reuben J.
    Singh, Jaswant
    Pierson, Roger
    Naile, Jonathan
    Giesy, John P.
    Chang, Hong
    Higley, Eric
    Hecker, Markus
    Adams, Gregg P.
    REPRODUCTION FERTILITY AND DEVELOPMENT, 2012, 24 (04) : 631 - 640
  • [26] Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer
    Chin, Y. S.
    Beresford, M. J.
    Ravichandran, D.
    Makris, A.
    BREAST, 2007, 16 (04): : 436 - 439
  • [27] 2- and 3-[(Aryl)(azolyl)methyl]indoles as Potential Non-steroidal Aromatase Inhibitors
    Lézé, MP
    Le Borgne, M
    Marchand, P
    Loquet, D
    Kogler, M
    Le Baut, G
    Palusczak, A
    Hartmann, RW
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (06) : 549 - 557
  • [28] Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 167 - 167
  • [29] Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1
    Camilla Fusi
    Serena Materazzi
    Silvia Benemei
    Elisabetta Coppi
    Gabriela Trevisan
    Ilaria M. Marone
    Daiana Minocci
    Francesco De Logu
    Tiziano Tuccinardi
    Maria Rosaria Di Tommaso
    Tommaso Susini
    Gloriano Moneti
    Giuseppe Pieraccini
    Pierangelo Geppetti
    Romina Nassini
    Nature Communications, 5
  • [30] Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
    Nazli Bahrami
    Shakila Jabeen
    Andliena Tahiri
    Torill Sauer
    Hilde Presterud Ødegård
    Stephanie Beate Geisler
    Berit Gravdehaug
    Laurens Cornelus Reitsma
    Knut Selsås
    Vessela Kristensen
    Jürgen Geisler
    Breast Cancer Research and Treatment, 2021, 190 : 435 - 449
12345